We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biogen's MS Drug Avonex Subject of MedWatch Alert
Biogen's MS Drug Avonex Subject of MedWatch Alert
March 18, 2005
The FDA has issued a MedWatch alert for Biogen Idec’s multiple sclerosis (MS) drug Avonex, which the agency says can cause severe liver damage, including liver failure.